EDN1 and Alzheimer disease: Studies on amyloid-β peptide (Aβ) interaction with the vasculature have shown that ET-1 mediates oxidative stress through the receptor for advanced glycosylation end products (RAGE), leading to reduction in blood flow in AD mice24.